Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
InterMedSo Luxembourg from Arlon, company number BE0766915355, closed financial year 2025 with a result of € 57,847 after tax. For that financial year InterMedSo Luxembourg recorded a gross margin of € 96,404 and equity of € 2 million. Compared with financial year 2024, the result moved from € 154,717 to € 57,847. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 23, 2026.
€ 2 million
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 57,847
▼ 63% vs 2024
Profit after tax over the fiscal year.
€ 156,493
▲ 47% vs 2024
Cash and bank balances on the last day of the fiscal year.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 7,839
▲ 4% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 711
▼ 68% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 81,665 | € 132,485 | € 162,599 | € 96,404 | ▼ 41% |
| Profit after taxes | € 76,835 | € 145,347 | € 154,717 | € 57,847 | ▼ 63% |
| Equity | € 1,685,114 | € 1,830,462 | € 1,985,179 | € 2,043,026 | ▲ 3% |
| Total debts | € 54,732 | € 32,250 | € 13,775 | € 11,559 | ▼ 16% |
| Cash | € 570,746 | € 783,838 | € 106,155 | € 156,493 | ▲ 47% |
| Retained profit | € 72,062 | € 217,410 | € 400,000 | € 457,847 | ▲ 14% |
| Balance sheet total | € 1,739,847 | € 1,862,712 | € 1,998,954 | € 2,054,585 | ▲ 3% |
Key figures of InterMedSo Luxembourg, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to InterMedSo Luxembourg?
What happened at InterMedSo Luxembourg in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Catherine PLAINCHAMP stepped down as director. NBB
- Marie-Louise SCHUL stepped down as director. NBB
- Hugues CREMER stepped down as director. NBB
- Damien VANDERSTICHELEN stepped down as director. NBB
- Robert PIRSON stepped down as director. NBB
- Valérie SKA stepped down as director. NBB
- Daniel ANTOINE stepped down as director. NBB
- Alain KLEINKENBERG stepped down as director. NBB
In short
From € 76,835 profit in 2022 to € 57,847 profit in 2025.
Best year ever: 2024, with € 154,717 profit.
A new publication or filing at InterMedSo Luxembourg? We notify you, reason included.
Follow InterMedSo LuxembourgDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Catherine PLAINCHAMP
Director
Also active at: Intégration Sociale et Travail, Espace Solival, L'EGLANTINE
since 2021 · until 2028
Marie-Louise SCHUL
Director
since 2022 · until 2028
Hugues CREMER
Director
since 2022 · until 2028
Damien VANDERSTICHELEN
Vice-chairman of the board
Also active at: Cabinet Médical du Docteur VANDERSTICHELEN
since 2022 · until 2028
Claude ROLIN
Director
Also active at: L'Economie Populaire, Nationaal Hulpfonds-Fonds National d'Entraide, CREAGORA
since 2021 · until 2025
since 2021 · until 2028
Valérie SKA
Managing director
since 2025 · until 2028
since 2022 · until 2028
Alain KLEINKENBERG
Director
since 2021 · until 2028
Andrée KERGER
Chairman of the board
since 2022 · until 2028
Establishments
Establishment units
Physical locations of this company
Rue de la Moselle 7-9
6700 Arlon
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0766.915.355
- VAT number
- BE 0766.915.355
- Registered office
- Rue de la Moselle 7-9, 6700 Arlon
- Names & denominations
- InterMedSo Luxembourg · InterMedSo Lux
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 20 April 2021
- Peppol
- Active · Active since 13 Feb 2025
- Activities · NACE
Diverse ondersteunende activiteiten ten behoeve van voorzieningen